Skip to main content
Signal8
BIGAL MARCELO profile photo

Marcelo Bigal

CIK: 0001996637

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Pacira BioSciences, Inc. logo
PCRX

Pacira BioSciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Pacira BioSciences, Inc. logo
    PCRX

    Pacira BioSciences, Inc.

    Jun 10, 2026
    Award(A)
    Direct
    6.4K shares-
  • Pacira BioSciences, Inc. logo
    PCRX

    Pacira BioSciences, Inc.

    Aug 7, 2025
    Sale(S)
    Direct
    4.9K shares at avg. $23.67$116K
  • Pacira BioSciences, Inc. logo
    PCRX

    Pacira BioSciences, Inc.

    Jun 11, 2025
    Award(A)
    Direct
    6.2K shares-

1-3 of 3

About BIGAL MARCELO

BIGAL MARCELO (SEC CIK 0001996637) files insider reports with the SEC as Director of Pacira BioSciences, Inc. (PCRX).

Signal8 holds 3 ownership filings by BIGAL MARCELO, all Form 4s, filed between Jun 13, 2025 and Jun 12, 2026. Those filings report 3 transactions, from Jun 11, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on BIGAL MARCELO's filings is in BRISBANE, CA.

Recent filings by BIGAL MARCELO

  • Jun 10, 2026: Grant or award of PCRX shares (Form 4, code A).
  • Aug 7, 2025: Open-market sale of PCRX shares (Form 4, code S).
  • Jun 11, 2025: Grant or award of PCRX shares (Form 4, code A).

Other insiders filing for Pacira BioSciences, Inc. (PCRX)

How to read Form 4 transaction codes